A Hepatocellular Carcinoma Targeting Nanostrategy with Hypoxia-Ameliorating and Photothermal Abilities that, Combined with Immunotherapy, Inhibits Metastasis and Recurrence
文献类型:期刊论文
作者 | Zhou, Tianjun3,4,7; Liang, Xiaolong2![]() ![]() ![]() ![]() |
刊名 | ACS NANO
![]() |
出版日期 | 2020-10-27 |
卷号 | 14期号:10页码:12679-12696 |
关键词 | hepatocellular carcinoma prussian blue photothermal therapy sorafenib hypoxia antiprogrammed death-ligand I immunotherapy |
ISSN号 | 1936-0851 |
DOI | 10.1021/acsnano.0c01453 |
通讯作者 | Du, Yang(yang.du@ia.ac.cn) ; Fang, Chihua(fangch_dr@163.com) ; Tian, Jie(jie.tian@ia.ac.cn) |
英文摘要 | Hepatocellular carcinoma (HCC) is a common and highly malignant tumor that is prone to recurrence and metastasis and has no effective treatment. Unsurprisingly, its prognosis is quite poor; early detection methods and effective low toxicity treatments are urgently needed. To achieve these goals, we designed a multifunctional, U.S. Food and Drug Administration-approved Prussian blue (PB) nanoparticle (NP) with a porous metal organic frame loaded with sorafenib l (SF), conjugated with HCC-specific targeting peptide SP94 and the near-infrared dye cyanine (Cy)S.S. These NPs are amenable to multimodal imaging for dynamic monitoring of their biodistribution and tumor-targeting effects. The SP94-PB-SF-Cy5.5 NPs achieved targeted delivery and controlled SF release and exhibited good photothermal effects. In this strategy, photothermal therapy and SF treatment complement each other, reducing the side effects of SF and achieving a therapeutic effect without local tumor recurrence. In addition, the catalase-like ability of l the NPs alleviates tumor hypoxia, and their photothermal effects l induce immunogenic cell death, leading to the release of tumor-associated antigens. These effects combine to trigger an antitumor immune response; the NPs also displayed promising inhibitory effects on tumor metastasis and recurrence and produced an abscopal effect and long-term immunological memory when combined with antiprogrammed death-ligand I (PD-LI) immunotherapy. These safe, multifunctional NPs represent a valuable treatment option for HCC. In addition, this next-generation treatment model may provide some ideas for the management of HCC and other cancers. |
WOS关键词 | PRUSSIAN BLUE NANOPARTICLES ; CHECKPOINT BLOCKADE ; T-CELLS ; CANCER ; GENERATION ; IMMUNITY ; THERAPY ; SIGNALS |
资助项目 | National Natural Science Foundation of China[81627805] ; National Natural Science Foundation of China[81871514] ; National Natural Science Foundation of China[81822022] ; National Natural Science Foundation of China[81771846] ; National Key Research and Development Program of China[2 0 1 7YFAO 2 0 5 2 0 0] ; National Key Research and Development Program of China[2017YFA0700401] ; National Key Research and Development Program of China[2016YFA0100902] ; National Key Research and Development Program of China[2016YFC0106500] ; Science and Technology Plan Project of Guangzhou[201604020144] ; Science and Technology Plan Project of Guangzhou[201704020141] ; NSFC-GD Union Foundation[U1401254] ; Beijing Excellent Young Talents Training Support Program[2018000021223ZK48] ; Peking University Third Hospital[BYSYZD2019018] ; Peking University Third Hospital[jyzc2018-02] ; Peking University Third Hospital[BYSY2015023] |
WOS研究方向 | Chemistry ; Science & Technology - Other Topics ; Materials Science |
语种 | 英语 |
WOS记录号 | WOS:000586793400026 |
出版者 | AMER CHEMICAL SOC |
资助机构 | National Natural Science Foundation of China ; National Key Research and Development Program of China ; Science and Technology Plan Project of Guangzhou ; NSFC-GD Union Foundation ; Beijing Excellent Young Talents Training Support Program ; Peking University Third Hospital |
源URL | [http://ir.ia.ac.cn/handle/173211/42677] ![]() |
专题 | 自动化研究所_中国科学院分子影像重点实验室 |
通讯作者 | Du, Yang; Fang, Chihua; Tian, Jie |
作者单位 | 1.Beihang Univ, Beijing Adv Innovat Ctr Big Data Based Precis Med, Sch Med, Beijing 100191, Peoples R China 2.Peking Univ Third Hosp, Dept Ultrasound, Beijing 100191, Peoples R China 3.Chinese Acad Sci, Inst Automat, CAS Key Lab Mol Imaging, State Key Lab Management & Control Complex Syst, Beijing 100190, Peoples R China 4.Southern Med Univ, Zhujiang Hosp, Dept Hepatobiliary Surg, Guangzhou 510280, Peoples R China 5.Beijing Ctr Dis Control & Prevent, Beijing Key Lab Diagnost & Traceabil Technol Food, Beijing 100013, Peoples R China 6.Univ Chinese Acad Sci, Beijing 100049, Peoples R China 7.Prov Clin & Engn Ctr Digital Med, Guangzhou 510280, Peoples R China |
推荐引用方式 GB/T 7714 | Zhou, Tianjun,Liang, Xiaolong,Wang, Peifeng,et al. A Hepatocellular Carcinoma Targeting Nanostrategy with Hypoxia-Ameliorating and Photothermal Abilities that, Combined with Immunotherapy, Inhibits Metastasis and Recurrence[J]. ACS NANO,2020,14(10):12679-12696. |
APA | Zhou, Tianjun.,Liang, Xiaolong.,Wang, Peifeng.,Hu, Yueyang.,Qi, Yafei.,...&Tian, Jie.(2020).A Hepatocellular Carcinoma Targeting Nanostrategy with Hypoxia-Ameliorating and Photothermal Abilities that, Combined with Immunotherapy, Inhibits Metastasis and Recurrence.ACS NANO,14(10),12679-12696. |
MLA | Zhou, Tianjun,et al."A Hepatocellular Carcinoma Targeting Nanostrategy with Hypoxia-Ameliorating and Photothermal Abilities that, Combined with Immunotherapy, Inhibits Metastasis and Recurrence".ACS NANO 14.10(2020):12679-12696. |
入库方式: OAI收割
来源:自动化研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。